Everything below concerns lyophilized powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Acetylated heptapeptide form |
| Monoisotopic mass | 888.5 Da | Average mass about 889 Da |
| Appearance | White to off-white solid | Usually supplied as lyophilised powder |
| Solubility class | Highly water soluble | Also dissolves in aqueous buffers |
| Common synonyms | Tbeta4 fragment, thymosin beta-4 (17-23) | Refer to the same sequence |
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
The Humboldt party departed Mexico City on January 20, 1804, heading for Puebla and Veracruz, taking with them a wealth of scientific material and observations. On March 7, 1804, Humboldt departed from Veracruz, sailing to Havana to recover the scientific collections he had stored there more than three years earlier for safekeeping. Previously, when Humboldt attempted to join Baudin in Lima, it appeared he had abandoned any intention of traveling to the northern regions of the American continent. In late November 1802, he wrote to the Institut National in Paris, stating his hope to return to Europe through Mexico and Cuba by the following autumn. In his letter, Humboldt emphasized his focus on preserving and publishing his manuscripts and expressed a strong desire to be in Paris. However, his decision to delay his return and visit the United States emerged at the last moment. This change was likely inspired by his deep admiration for the American President, Thomas Jefferson, whom Humboldt felt compelled to meet before leaving the New World. His interest was further heightened by curiosity about Jefferson’s initiatives for exploring the American West.
=== Neuronal membrane === The brain preferentially uses choline to synthesize acetylcholine. This limits the amount of choline available to synthesize phosphatidylcholine. When the availability of choline is low or the need for acetylcholine increases, phospholipids containing choline can be catabolized from neuronal membranes. These phospholipids include sphingomyelin and phosphatidylcholine. Supplementation with citicoline can increase the amount of choline available for acetylcholine synthesis and aid in rebuilding membrane phospholipid stores after depletion. Citicoline decreases phospholipase stimulation. This can lower levels of hydroxyl radicals produced after an ischemia and prevent cardiolipin from being catabolized by phospholipase A2. It can also work to restore cardiolipin levels in the inner mitochondrial membrane.
Platelets also promote angiogenesis and tissue regeneration to maintain overall vascular integrity by releasing growth factors like vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). Their multifunctional role displays the challenge of innovating synthetic platelets capable of effectively replicating their physiological functions.
Sources: en.wikipedia.org
== General relativity == General relativity introduces new phenomena. In an expanding universe, photons spontaneously redshift and tethers spontaneously gain tension; if vacuum energy is positive, the total vacuum energy of the universe appears to spontaneously increase as the volume of space increases. Some scholars claim that energy is no longer meaningfully conserved in any identifiable form. John Baez's view is that energy–momentum conservation is not well-defined except in certain special cases. Energy-momentum is typically expressed with the aid of a stress–energy–momentum pseudotensor. However, since pseudotensors are not tensors, they do not transform cleanly between reference frames. If the metric under consideration is static (that is, does not change with time) or asymptotically flat (that is, at an infinite distance away spacetime looks empty), then energy conservation holds without major pitfalls. In practice, some metrics, notably the Friedmann–Lemaître–Robertson–Walker metric that appears to govern the universe, do not satisfy these constraints and energy conservation is not well defined. Besides being dependent on the coordinate system, pseudotensor energy is dependent on the type of pseudotensor in use; for example, the energy exterior to a Kerr–Newman black hole is twice as large when calculated from Møller's pseudotensor as it is when calculated using the Einstein pseudotensor.
Early specimens represent birds that were pets or came from menageries. The oldest surviving bird specimens include an African grey parrot once owned by Frances Teresa Stuart (1647–1702) that was buried with its owner in London’s Westminster Abbey. Several mummified ibis and falcons have been recorded from Egyptian tombs dating from 600 to 300 BC. Bird specimens obtained from the 18th century for natural history collections were most often obtained using firearms. Shotguns with "dust" shot were preferred to reduce damage to the specimens. Today, specimens come from a variety of sources. Many (perhaps most) are salvaged from birds killed by window and communications tower strikes, domestic cats, by-catch from fisheries, die-offs from disease, vehicle strikes, and other accidental sources of mortality. However, the world's bird collections have been argued to be inadequate in documenting avian diversity, from taxonomic, geographic, and temporal perspectives, with some parts of tropical regions considered under-represented in particular museums. Underrepresented taxa continue to be actively collected by ornithologists, generally using either firearms or mist-nets. Permitting agencies oversee these activities in most countries.
Before the release of the Dexcom G6, users of the Dexcom CGM system had to manually insert the sensor using a syringe-like applicator. This process was often painful, error-prone, and involved multiple steps, requiring up to 11 actions to complete the sensor insertion. As a result, the process was cumbersome and uncomfortable for many users. With the release of the G6 auto-applicator, the design was significantly improved. The updated applicator features a one-touch, one-hand operation, simplifying the process and reducing the steps from eleven to four. It also utilizes a fast needle mechanism that quickly moves in and out of the skin, minimizing discomfort and making the insertion nearly painless. This redesign made the process easier and more accessible, particularly for parents using the system with young children.
Sources: en.wikipedia.org
== Structural studies == As of late 2007, 12 structures have been solved for this class of enzymes, with PDB accession codes PDB: 1EVY, PDB: 1EVZ, PDB: 1JDJ, PDB: 1M66, PDB: 1M67, PDB: 1N1E, PDB: 1N1G, PDB: 1WPQ, PDB: 1X0V, PDB: 1X0X, PDB: 1YJ8, and PDB: 1Z82.
Peter V'landys was appointed Chair on 30 October 2019, replacing Peter Beattie who reverted to a commissioner role. Beattie had served as Chair since February 2018. Andrew Abdo served as Interim CEO from late April 2020 until his appointment as CEO in early September 2020.
=== Beverages === Buckwheat tea, known as kuqiao-cha (苦荞茶) in China, memil-cha (메밀차) in Korea and soba-cha (蕎麦茶) in Japan, is a tea made from roasted buckwheat. Buckwheat has been used as a substitute for other grains in gluten-free beer. It is used in the same way as barley to produce a malt that can form the basis of a mash that will brew a beer without gliadin or hordein (together gluten) and therefore can be suitable for coeliacs or others sensitive to certain glycoproteins. Buckwheat whisky is a distilled alcoholic beverage made from buckwheat. It is produced in the Brittany region of France and in the United States. Buckwheat shōchū (焼酎) is a Japanese distilled beverage produced since the 16th century. The taste is milder than barley shōchū.
Sources: en.wikipedia.org
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.
It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.
Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.